📄 "Population-scale sequencing resolves determinants of persistent EBV DNA" . EBV ( January 29, 2026 at 04:49AM)
https://pubmed.ncbi.nlm.nih.gov/41606327/?utm_source=Feedly&utm_medium=rss&utm_campaign=None&utm_content=0QA_9LuQeZiNtqHBsduJlC5R9OwbuQKm4WoBORUOvGl&fc=None&ff=20260129024950&v=2.18.0.post22+67771e2

📄 "A threshold in anti-EBNA-1 antibody titers distinguishes salivary EBV shedders from non-shedders" . EBV ( January 6, 2026 at 10:28PM)
https://pubmed.ncbi.nlm.nih.gov/41493209/?utm_source=Feedly&utm_medium=rss&utm_campaign=None&utm_content=0QA_9LuQeZiNtqHBsduJlC5R9OwbuQKm4WoBORUOvGl&fc=None&ff=20260106202816&v=2.18.0.post22+67771e2

📄 "Chronic Active Epstein-Barr Virus Disease: Molecular Pathogenesis, Evolving Concepts, and Emerging Therapies" . EBV ( January 6, 2026 at 04:07PM)
https://pubmed.ncbi.nlm.nih.gov/41490284/?utm_source=Feedly&utm_medium=rss&utm_campaign=None&utm_content=0QA_9LuQeZiNtqHBsduJlC5R9OwbuQKm4WoBORUOvGl&fc=None&ff=20260106140734&v=2.18.0.post22+67771e2

📄 "The Biology and Clinical Utility of EBV Monitoring in Blood" . EBV ( February 3, 2026 at 06:01PM)
https://pubmed.ncbi.nlm.nih.gov/41632221/?utm_source=Feedly&utm_medium=rss&utm_campaign=None&utm_content=0QA_9LuQeZiNtqHBsduJlC5R9OwbuQKm4WoBORUOvGl&fc=None&ff=20260203160139&v=2.18.0.post22+67771e2

📄 "Epstein-Barr Virus Infection at Single-Cell Resolution" . EBV ( February 5, 2026 at 08:29PM)
https://pubmed.ncbi.nlm.nih.gov/41641929/?utm_source=Feedly&utm_medium=rss&utm_campaign=None&utm_content=0QA_9LuQeZiNtqHBsduJlC5R9OwbuQKm4WoBORUOvGl&fc=None&ff=20260205182942&v=2.18.0.post22+67771e2

📄 "Establishment of an Epstein-Barr virus infection model using human nasal organoids" . EBV ( February 4, 2026 at 08:30AM)
https://pubmed.ncbi.nlm.nih.gov/41633691/?utm_source=Feedly&utm_medium=rss&utm_campaign=None&utm_content=0QA_9LuQeZiNtqHBsduJlC5R9OwbuQKm4WoBORUOvGl&fc=None&ff=20260204063001&v=2.18.0.post22+67771e2

📄 "Research on EBV-miR-BART17-5p targeted Inhibition of ARID1A expression to regulate nasopharyngeal carcinoma dedifferentiation" . EBV ( February 14, 2026 at 08:45AM)
https://pubmed.ncbi.nlm.nih.gov/41689061/?utm_source=Feedly&utm_medium=rss&utm_campaign=None&utm_content=0QA_9LuQeZiNtqHBsduJlC5R9OwbuQKm4WoBORUOvGl&fc=None&ff=20260214064459&v=2.18.0.post22+67771e2

📄 "Long noncoding RNA ADEI/miR-93-3p/STAT3 axis promotes Epstein-Barr virus-positive diffuse large B-cell lymphoma progression and immune evasion through regulating the PD-1/PD-L1 checkpoint" . Vírus e Câncer ( March 4, 2026 at 06:15AM)
https://pubmed.ncbi.nlm.nih.gov/41775689/?utm_source=Feedly&utm_medium=rss&utm_campaign=None&utm_content=0u90aheep466_8QQJ_eCsFFK8hoDV096ilWAIPckjVx&fc=None&ff=20260304041531&v=2.19.0.post6+133c1fe

📄 "Epstein-Barr virus-associated lymphoma: current understanding and treatment strategies" . Vírus e Câncer ( March 7, 2026 at 08:33PM)
https://pubmed.ncbi.nlm.nih.gov/41793645/?utm_source=Feedly&utm_medium=rss&utm_campaign=None&utm_content=0u90aheep466_8QQJ_eCsFFK8hoDV096ilWAIPckjVx&fc=None&ff=20260307183311&v=2.19.0.post6+133c1fe

📄 "EBV-dUTPase Modulates Host Immune Responses Potentially Altering the Tumor Microenvironment in EBV-associated Malignancies" . EBV ( March 16, 2026 at 08:17AM)
https://pubmed.ncbi.nlm.nih.gov/41835621/?utm_source=Feedly&utm_medium=rss&utm_campaign=None&utm_content=0QA_9LuQeZiNtqHBsduJlC5R9OwbuQKm4WoBORUOvGl&fc=None&ff=20260316071705&v=2.19.0.post6+133c1fe

📄 "Epstein-Barr virus drives nasopharyngeal carcinoma metastasis via RNA m(5)C modification of ICAM-1 mediated by NSUN2 and YBX3" . Virus & Cancer progression ( March 19, 2026 at 10:53AM)
https://pubmed.ncbi.nlm.nih.gov/41851283/?utm_source=Feedly&utm_medium=rss&utm_campaign=None&utm_content=1JYY-CLhi6S_qYgewYYLcsVbmJ49tbTqE5imhffwnPvov_JwLZ&fc=None&ff=20260319095258&v=2.19.0.post6+133c1fe

📄 "Discovery and validation of biomarkers for Epstein-Barr virus associated gastric cancer" . EBV ( March 25, 2026 at 09:59AM)
https://pubmed.ncbi.nlm.nih.gov/41877627/?utm_source=Feedly&utm_medium=rss&utm_campaign=None&utm_content=0QA_9LuQeZiNtqHBsduJlC5R9OwbuQKm4WoBORUOvGl&fc=None&ff=20260325085919&v=2.19.0.post6+133c1fe

📄 "Epstein-Barr Virus: From the Detection of Sequence Polymorphisms to the Recognition of Viral Strains" . EBV ( March 26, 2026 at 05:37PM)
https://pubmed.ncbi.nlm.nih.gov/41885946/?utm_source=Feedly&utm_medium=rss&utm_campaign=None&utm_content=0QA_9LuQeZiNtqHBsduJlC5R9OwbuQKm4WoBORUOvGl&fc=None&ff=20260326163751&v=2.19.0.post6+133c1fe

📄 "KSHV and Human Diseases: Beyond KS, PEL and MCD" . KSHV/HHV-8 ( March 28, 2026 at 10:19AM)
https://pubmed.ncbi.nlm.nih.gov/41900396/?utm_source=Feedly&utm_medium=rss&utm_campaign=None&utm_content=0MbwdG8oCHuS3zShObm9OxM2igUrv8WmS1-6Xt5ghCU&fc=None&ff=20260328091956&v=2.19.0.post6+133c1fe

📄 "A comparison of Epstein-Barr virus digital PCR and quantitative PCR for identifying nasopharyngeal cancer" . EBV ( April 1, 2026 at 09:56PM)
https://pubmed.ncbi.nlm.nih.gov/41920762/?utm_source=Feedly&utm_medium=rss&utm_campaign=None&utm_content=0QA_9LuQeZiNtqHBsduJlC5R9OwbuQKm4WoBORUOvGl&fc=None&ff=20260401205601&v=2.19.0.post6+133c1fe

📄 "Epstein-Barr virus orchestrates spatial reorganization and immunomodulation in the classic Hodgkin lymphoma tumor microenvironment" . EBV lymphomas ( April 2, 2026 at 09:30AM)
https://pubmed.ncbi.nlm.nih.gov/41923627/?utm_source=Feedly&utm_medium=rss&utm_campaign=None&utm_content=07TGfd6xW8ejZCqVe2KpX2yGR1RKzfVyM7Wv85wXgoA&fc=None&ff=20260402083057&v=2.19.0.post6+133c1fe

📄 "A comparison of Epstein-Barr virus digital PCR and quantitative PCR for identifying nasopharyngeal cancer" . Vírus e Câncer ( April 1, 2026 at 08:25PM)
https://pubmed.ncbi.nlm.nih.gov/41920762/?utm_source=Feedly&utm_medium=rss&utm_campaign=None&utm_content=0u90aheep466_8QQJ_eCsFFK8hoDV096ilWAIPckjVx&fc=None&ff=20260401192523&v=2.19.0.post6+133c1fe

📄 "Development and validation of a duplex droplet digital PCR assay for the simultaneous detection of cytomegalovirus and Epstein-Barr virus in plasma" . EBV ( April 6, 2026 at 04:14PM)
https://pubmed.ncbi.nlm.nih.gov/41938868/?utm_source=Feedly&utm_medium=rss&utm_campaign=None&utm_content=0QA_9LuQeZiNtqHBsduJlC5R9OwbuQKm4WoBORUOvGl&fc=None&ff=20260406151422&v=2.19.0.post6+133c1fe

📄 "Hit-and-run hypothesis: revisiting the impact of EBV in malignancies" . EBV ( April 9, 2026 at 10:21AM)
https://pubmed.ncbi.nlm.nih.gov/41953038/?utm_source=Feedly&utm_medium=rss&utm_campaign=None&utm_content=0QA_9LuQeZiNtqHBsduJlC5R9OwbuQKm4WoBORUOvGl&fc=None&ff=20260409092121&v=2.19.0.post6+133c1fe

📄 "Integrating Epstein-Barr virus (EBV) status into diffuse large B cell lymphoma (DLBCL) genetics" . Vírus e Câncer ( April 10, 2026 at 09:55AM)
https://pubmed.ncbi.nlm.nih.gov/41958986/?utm_source=Feedly&utm_medium=rss&utm_campaign=None&utm_content=0u90aheep466_8QQJ_eCsFFK8hoDV096ilWAIPckjVx&fc=None&ff=20260410085529&v=2.19.0.post6+133c1fe

📄 "EBV Genome Variations and Association With Diseases" . EBV ( April 13, 2026 at 08:28AM)
https://pubmed.ncbi.nlm.nih.gov/41969124/?utm_source=Feedly&utm_medium=rss&utm_campaign=None&utm_content=0QA_9LuQeZiNtqHBsduJlC5R9OwbuQKm4WoBORUOvGl&fc=None&ff=20260413072813&v=2.19.0.post6+133c1fe